Alexander Chernykh

Biography

 Over 11 years secured patients’ access to the best available health technologies. Made a sophisticated professional path in pharmaceutical industry at the different roles, which covered retail, R&D and market access matters in oncology, hematology, immunology, endocrinology and neurology. In the period of 2006 – 2013 served for both TOP-30 pharmaceutical and small biotech companies including CROs where demonstrated a significant performance in Clinical Operations. In the period of December 2013 – August 2015 worked at "EVER Pharma GmbH" in the role of Market Access Manager. Developed and implemented market access strategies in regional market access affairs, supported state procurements via EDL, ONLS, TPGG (regional l’gota) listing. Managed enlisting of Cerebrolysin into 11 federal medical care standards in child neurology and psychiatry, 16 federal clinical guidelines in child neurology, psychiatry, narcology), pharmacoeconomical modeling study and special regional programs in TBI, stroke and POCD treatment thus ensuring the extra access of patients to Cerebrolysin in-line with Health Care Policy, estimated company budgets and cross-function interaction. Conducted tens of internal trainings on compliance, legal and market access affairs additionally reinforcing company effectiveness.

Research Interest

 Psychiatry